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SalinomycinMonitoring of autophagy is challenging because of its multiple steps and lack of single beﬁtting technique for a
complete mechanistic understanding, which makes the task complicated. Here, we evaluate the functionality
of autophagy triggered by salinomycin (anti-cancer stem cell agent) using ﬂow cytometry and advancedmicros-
copy.We show that salinomycin does induce functional autophagy at lower concentrations and such a dose is cell
type-dependent. For example, PC3 cells show active autophagic ﬂux at 10 μMconcentration of salinomycinwhile
murine embryonic ﬁbroblasts already show an inhibition of ﬂux at such doses. A higher concentration of
salinomycin (i.e. 30 μM) inhibits autophagic ﬂux in both cell types. The data conﬁrms our previous ﬁndings
that salinomycin is an inducer of autophagy, whereas autophagic ﬂux inhibition is a secondary response.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Autophagy is the primary cellularmetabolic stress-induced catabolic
response that converts organelles, pathogens and cellular debris to its
building blocks that are eventually recycled. A dysfunctional autophagy
promotes carcinogenesis, while a functional autophagy is necessary for
cancer cell survival under extreme conditions of hypoxia and nutrient
deprivation [1]. Thus, the deﬁnition of chemotherapeutic agents in
their role as either inducers or inhibitors of functional autophagy is
pivotal for proper planning of treatment. The complexity of autophagic
process and the lack of one robust standard technique to follow its pro-
gressionwarrant the employment of several techniques. Standardization
of techniques to precisely monitor autophagy is constantly evolving [2].
Macroautophagy, referred to in this article as autophagy, triggered
either by activation of class III PI3-kinases or inhibition of class I PI3-
kinases, initiates the formation of an initial phagophore that matures
to a double-membraned envelope, which engulfs the substrates. The
engulfed material is then degraded upon fusion with acidic lysosomes.
The initiation of autophagy is a tightly regulated sequential process
governed by multiprotein complexes composed of autophagy-related
proteins. To name a few examples in sequential order during autophagy
initiation: Beclin1, ATG5, ATG7 and LC3 (ATG8) along with other cellu-
lar proteins, those that are degraded by autophagy like p62/SQSTRM1and Experimental Medicine,
öping University, Cell Biology
0 10 32787.are traced to identify functional autophagy. Beclin1marks the initiation
of autophagy, and forms a complex with autophagy initiation multimer
involvingUVRAGandUMBRA [3]. This initiation is followed by the elon-
gation of the phagophore through ATG5- and ATG7-dependent mecha-
nisms leading to the lipidation of LC3 to form LC3II and consequent
recruitment to the elongating phagophore [3]. Thus, mitigation of
LC3II acts as a major tool to evaluate the elongation of the phagophore.
LC3II is localized on either side of the membrane. Upon maturation of
the autophagosome by fusing with lysosomes, part of LC3II localized
to the inner membrane gets degradedwhile the rest on the outer mem-
brane is recycled. Hence, monitoring of LC3 is widely used as it acts not
only as amarker for autophagy induction but also to studymaturation of
the autophagosome. More notably, autophagy monitoring studies using
tagged LC3with either GFP (greenﬂorescent protein) alone, orwith tan-
dem GFP and RFP (red ﬂorescent proteins), or most recently, Wasabi as
a replacement for GFP has become the standard [4]. Since lysosomes ul-
timately deﬁne the active, functional autophagy, staining of these acidic
organelles, to determine the number of lysosomes and their localization
to autophagosomes (their fusion marks the completion of autophagic
process), are also frequently used for monitoring autophagy.
Streptomyces albus–derived ionophore salinomycin (Sal) is widely
studied because of its potency to kill cancer stem–like cells [5,6]. We,
alongwith other groups, have shown that salinomycin’s toxicity towards
cancer and cancer stem cells depends on the disruption of function of
mitochondria [6,7]. We employ a wide range of breast cancer, prostate
cancer and normal primary human cells to show that salinomycin toxic-
ity is concentration-, time- and cell type–dependent with least toxicity
towards normal primary ﬁbroblasts [6]. However, there are conﬂicting
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Li and colleagues [8], show that salinomycin induces autophagic ﬂux,
while Yue and collaborators [9] show salinomycin as an inhibitor of func-
tional autophagy without altering the lysosomal acidity but through
an unknown mechanism of attenuating lysosomal proteases. The com-
parison is complicated by the fact that all the above-mentioned studies
employed different cancer cellular models [6,8,9]. So, in this brief report,
we evaluate autophagy induced by salinomycin employing a variety of
techniques including recently developed ﬂow cytometry techniques,
and live cell imaging approaches [10–12]. We show that salinomycin-
induced autophagic ﬂux is dose-, and cell type–dependent.
2. Results
2.1. Salinomycin is an inducer of autophagy and autophagic ﬂux
We initially identiﬁed the salinomycin function in regulating autoph-
agic ﬂux using normal cells (MEF) and cancer cells (PC3 and SKBR3). As
a follow-up to our previous study, we assessed by Western blot the
ratiometric increase of LC3II accumulation in the presence of salinomycin
and chloroquine compared to either salinomycin or chlorquine alone [6].
As shown in Fig. 1A and Supplementary Fig. 1A, salinomycin-treated cells
(0.1 μM and 1 μM) and chloroquine-treated cells (25 μM) showed
increased accumulation of LC3II, but only cells treated with 0.1 μM Sal
showed a ratiometric increase in the presence of chloroquine. EvenA
B
Fig. 1. Salinomycin induces autophagic ﬂux. Autophagic ﬂuxwasmonitored through estimating
tions. LC3II showed increased levels upon salinomycin treatment (0.1 μM and 1 μM), but in the
(A). Even though 1 μM salinomycin-treated samples showed increase in LC3II accumulation in
degrade upon autophagy induction by salinomycin treatment, showing a functional autophagy
images of MEF cells expressing GFP-LC3 and treated with salinomycin show increased LC3 pun
treated cells show huge vacuoles with GFP-LC3 and clumping of vacuoles near the nucleus (B)though 1 μMSal (Fig. 1A) and 10 μMSal (Supplementary Fig. 1B) treated
cells showed increased accumulation of LC3II in the presence of chloro-
quine, they did not show a signiﬁcant difference compared to 1 μM Sal
and 10 μMSal treated cells alone, respectively. To remedy the possibility
that inhibition of autophagy by 25 μM Cq would only be partial, we in-
creased the concentration of chloroquine to 50 μM. In the presence of
50 μM Cq, a further increase in accumulation of LC3II occurred upon
10 μM Sal treatment as compared to Cq and 10 μM Sal-treated samples
independently (Supplementary Fig. 1B).
Autophagic ﬂux was further monitored using another autophagic
marker, p62/SQSTRM1, and the results correlated with that of LC3II
ﬂux. In the presence of salinomycin at 0.1 and 1 μM concentration,
p62/SQSTRM1 was directed towards proteolysis in PC3 and MEF
cells. The proteolysis of p62/SQSTRM1 was resistant to Cq pretreated,
inferring that salinomycin does induce functional autophagy at lower
concentrations (Fig. 1A and Supplementary Fig. 1A). However, there
was no increase of LC3 ﬂux in SKBR3 cells, and p62/SQSTRM1 levels
remained unaltered at 1 μM Sal regardless of the presence of chloro-
quine (Supplementary Fig. 1A). Thus, the dosage of salinomycin differ-
entially affects autophagic ﬂux among cell types.
2.2. Higher doses of salinomycin inhibits autophagic ﬂux
Based on our observations so far we hypothesized that salinomycin
could inhibit autophagic ﬂux at higher concentrations depending onLC3II and p62/SQSTM1 protein levels upon salinomycin treatment at different concentra-
presence of chloroquine 0.1 μM salinomycin-treated samples showed ratiometric increase
the presence of chloroquine it was only a linear increase (A). p62/SQSTM1 protein levels
and this degradation was inhibited upon chloroquine treatment (A). Confocal microscopy
ctae (B) but 1 μM salinomycin-treated cells show distinct dots (punctae) while the 30 μM
. N= 3, *p b 0.05.
606 J.R. Jangamreddy et al. / Biochimica et Biophysica Acta 1853 (2015) 604–610cell type as different cells have different toxicity doses of salinomycin.
To test this, a follow-up study with 1 μM and 30 μM salinomycin was
done. As shown in Fig. 1B, GFP-LC3 expressing MEF cells treated with
1 μM salinomycin showed distinct green autophagic punctae while the
control cells show homogeneous green ﬂorescence throughout the
cytoplasm. Even though cells treated with higher concentrations ofA
B
Fig. 2. Total or membrane-bound GFP-LC3 quantiﬁcation for autophagic ﬂux determination. GF
inhibitor chloroquine or alone are subjected to ﬂow cytometry to estimate the total green ﬂor
decreased median ﬂorescence intensity (MFI) of green ﬂorescence compared to control. Chlo
the presence of autophagic inducer (salinomycin or rapamycin) or by itself. Samples treated
that salinomycin at higher concentrations inhibits autophagic ﬂux (upper panel: A). MEF cells
estimation of LC3 bound to autophagic vacuoles shows increase in MFI both in the presence
autophagy (1 μM Sal and 0.25 μM Rap). Chloroquine pretreated cells in the presence of 1 μM
Sal (lower panel: A). Quantitative representation of MFI values either in the presence or absensalinomycin showed green punctae, many cells exhibit heterogeneity
in the punctae pattern as some cells show appearance of clumped GFP
vacuoles while others show distinct autophagic punctae (Fig. 1B).
Following this initial observation of distinct LC3II pattern of accumu-
lation among cells treated with different concentrations of salinomycin,
we employedﬂowcytometric approaches to enumerate the salinomycinP-LC3 expressing MEF cells treated with salinomycin either in the presence of autophagy
escence. Treatment with 1 μM salinomycin or 0.25 μM rapamycin (positive control) show
roquine treatment shows an increase in MFI due to the inhibition of autophagy either in
with 30 μM of salinomycin show similar increase in MFI as chloroquine and thus show
were treated with saponin to remove the cytoplasmic unbound GFP-LC3 to facilitate the
of inhibitors of functional autophagy (chloroquine and 30 μM Sal) as well as inducers of
Sal and 0.25 μM Rap shows tremendous increase in MFI but not in the presence of 30 μM
ce of saponin for the above (B). N= 4, *p b 0.05.
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previously by Shvets et al. and Eng et al. [10–12]. In the presence of
active autophagy, GFP-LC3 that is located to the inner membrane
of autophagosome gets degraded, while the rest is recycled a partial
decrease in green ﬂorescence is observed among cells treated with
1 μM Sal and 0.25 μM rapamycin (positive control). However, 30 μM
Sal, similar to 50 μM Cq, shows increased accumulation (shift to the
right in relevant histograms; Fig. 2A, upper panel). This shows that
salinomycin at higher concentrations inhibits autophagic ﬂux, while
at lower concentrations, it is an inducer of functional autophagy. Green
ﬂorescence even though showed partial increase in the presence of
both salinomycin and Cq, it did not show a ratiometric increase.
Next, we quantiﬁed the amount of GFP-LC3 localized to the
autophagosome membrane. To do that, we removed free, cytoplasmic
GFP-LC3 by permeabilization, thus we were able to directly quantify
the autophagosome ﬂorescence [12]. As shown in Fig. 2A (lowerA
B
Fig. 3. The dose of salinomycin that inhibits autophagic ﬂux depends on cell type. MEF Cells ov
ﬂorescence better than the red ﬂorescence while 30 μM Sal and chloroquine show an increase
the same pattern as MEF cells but even at 10 μM Sal shows active autophagic ﬂux with decreas
(B). N= 3.panel), cells permeabilized with 0.05% saponin after treatment with
either inhibitor of autophagy or inducers, showed an increase of green
ﬂorescence similar to the observation made using Western blotting.
As expected, salinomycin (1 μM and 30 μM), rapamycin (1 μM) and
Cq (50 μM) caused the increase of green ﬂorescence due to a rise in
autophagosome quantity. Similar to Western blotting results, 1 μM
Sal in the presence of Cq showed a ratiometric increase in green
ﬂorescence compared to 1 μM Sal or Cq alone; however, 30 μM Sal
did not show such increase. This data indicates that salinomycin at
higher concentrations does inhibit autophagic ﬂux. Similarly, ﬂow
cytometric quantiﬁcation of green and red ﬂuorescence among cells
expressing mTandem GFP-RFP LC3 showed lower green and red
ﬂorescence in the presence of autophagic inducers (1 μM Sal, 1 μM
rapamycin, and starvation), while chloroquine and 30 μM Sal showed
a decrease in both green and red ﬂorescence in both MEF and PC3
cells (Fig. 3AB).erexpressing mTandem-RPF-GFP-LC3 treated with 1 μM Sal for 6 h show decreased green
in green and red ﬂorescence compared to control cells (A). Similarly, PC3 cells also show
ed green and red ﬂorescence compared to control as rapamycin and starvation conditions
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Additionally, we monitored autophagic processes using live cell
imaging of GFP-LC3 expressing cells stained with Lysotracker red
after treatment with 1 μM Sal for 30 min. As shown in the Fig. 4A,
lysosomes are co-localized with autophagosomes by the 10th frame
(100 s) and a progressive degradation of green ﬂorescence is ob-
served with time along with ﬁnal decrease in lysosome count. We
further quantiﬁed total number of green punctae and lysosomes per
time point, and observed an increase in the number of lysosomes
and green punctae together with very synchronous ﬂuctuations in
the number of lysosomes and autophagosomes (Fig. 4B,C). Thus, effec-
tively showing that salinomycin induces active autophagy that func-
tions to degrade cellular organelles and proteins to counteract the
cellular stress.A
B C
Fig. 4. Co-localization of autophagosomes and lysosomes upon salinomycin treatment. GFP-LC3
Sal were imaged using time-lapse live cell microscopy with 10 s interval for 1 h. Red-staine
degradation of green and red ﬂorescence is observed from frame 100 (A). Using Bitplane I
autophagosomal count is estimated for each time frame. Frame 50 shows an increase in lys
to frame 10 (B). Graphical representation of lysosomal and autophagosomal count over the p
an increase in autophagosomal count followed by increased lysosomal count and eventual deg3. Discussion
The discovery of salinomycin’s cancer stem cell targeting ability,
in 2009, lead to intensive studies of its molecular mechanism of ac-
tion [5]. We, and others, have studied the autophagy triggered by
salinomycin [6,8,9]. Even though salinomycin is well-known to in-
duce autophagy that functions as a cell-protective mechanism, the
underlying mechanism is not fully understood, with some conﬂicting
reports recently published. For example, Yue and colleagues, in their
elaborate study using MCF7 and HMLER cancer stem cells, show that
salinomycin acts as an inhibitor of autophagic ﬂux [9]. On the contrary,
in our experimental system involving PC3 (prostate cancer cells), SKBR3
(breast cancer cells) and primary human dermal ﬁbroblast cells, as well
as cells used in the original paper by Li et al., we observed an active
autophagic ﬂux in salinomycin-treated cells [6,8].overexpressingMEF cells stainedwith lysotracker dye for 30min and treatedwith 0.1 μM
d lysosomes co-localize with the GFP-LC3 autophagosomes (frame 30) and an eventual
maris software to analyze 3D images obtained with time-lapse studied lysosomal and
osomal (red) count and their co-localization with green autophagic punctae compared
eriod of time among salinomycin-treated cells show a similar trend in ﬂuctuations with
radation (C). N= 3.
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further examined in detail salinomycin’s role in autophagic ﬂux, using
both normal murine embryonic ﬁbroblasts and prostate cancer PC3
cells. Utilizing the densitometric analysis of LC3II expression in the
presence of salinomycin and/orwith autophagic inhibitors (chloroquine
or baﬁlomycin), our study, as well as those conducted by Li and col-
leagues, shows a ratiometric increase at lower concentrations as com-
pared to individual treatments. However, only a partial increase of
LC3II was observed among cells treated with higher concentrations of
salinomycin (Fig. 1A and Supplementary Fig. 1). Furthermore, in this
study, the observation that 25 μM concentration of chloroquine treat-
ment was only partially able to inhibit LC3II turnover triggered by
salinomycin at higher concentration (10 μM). A concentration of 50 μM
chloroquine shows a rise in LC3II accumulation and displays the impor-
tance of effectively blocking autophagy activity depending on the ex-
tent of the autophagy trigger. Previous studies also show that LC3II
punctae are increased and co-localizewith lysosomes that remain acidic
upon salinomycin treatment [6,9]. However, Yue et al. further show that
salinomycin inhibits lysosomal proteases thus triggering the inhibition
of autophagic ﬂux [9].
Because of the limitations of microscopy in analyzing minor ﬂuctua-
tions,weusedﬂowcytometric quantiﬁcation ofﬂorescence. As presented
in Fig. 2 and Supplementary Fig. 3, GFP-LC3 expressing MEF and PC3, re-
spectively, treatment with 1 μM salinomycin showed a similar trend
as positive control rapamycin in decreasing green ﬂorescence intensity
(increased autophagy). However, 30 μMsalinomycin shows an increase
of the green ﬂorescence (decrease of autophagy) as autophagy inhibitor
chloroquine. Similar observations were made with mTandem GFP-RFP
LC3 with both green and red ﬂorescence (Fig. 3A,B). However, PC3
cells show decreased green and red ﬂorescence even at 10 μM concen-
tration (Fig. 3B). This demonstrates that salinomycin-mediated inhibi-
tion of autophagic ﬂux is dependent on cell type and dosage.
While conducting studies involving GFP-LC3 overexpression in
various cell lines, we observed that very high expression levels of the
GFP-LC3 (induction with more than 100 MOI of adenovirus), a strong
increase of the green ﬂuorescence signal could be observed regardless
of whether an activator or an inhibitor of autophagywas applied. There-
fore, it is important to achieve a moderate and equal expression of the
LC3-conjugated ﬂorescence proteins in cellular models cells used for
the assessment of the autophagic ﬂux.
Our time-lapse, live cell imaging further support our observations on
salinomycin-triggered autophagy in the context of an active lysosomal
function. Salinomycin causes severe vacuolization in the cytoplasm, as
observed in our time-lapse video (Supplementary Fig. 4). The initial
membrane for autophagic vessel formation also originated from sources
such as Golgi, endoplasmic reticulum, etc. [13]. Thus, to study autopha-
gic ﬂux, we preferred to use GFP-LC3 andmTandemGFP-RFP LC3 rather
than using Cyto-ID, which depends on membrane composition of the
vacuoles [14]. Some studies demonstrate that vacuolization acts as an
impediment for the completion of autophagic processes through dis-
ruption of lysosomal fusion with autophagosomes [15]. However,
since both our studies show no such disruption in the fusion of lyso-
somes with the autophagosomes upon salinomycin treatment, and
moreover, that the ability of ionophores to induce vacuolization is cell
type dependent, one cannot exclude that excessive vacuolization at
higher concentrations of salinomycin could play a secondary role in
the inhibition of autophagic ﬂux [14].
In conclusion, although autophagy is activated as a component of an
initial stress response (cell copingmechanism), under the conditions of
extreme stress that may cause cell death, autophagy could fail to pro-
vide protection, and also act as an enhancer of apoptosis. Several of
the otherwise autophagy-promoting factors like Ambra1, Atg4d and
ATG5, are differentially regulated upon cell death trigger [16–18].
Ambra1, which is mainly responsible for the initiation of autophagy, is
downregulated once the cell is committed to cell death, thus inhibiting
autophagy [16]. On the other hand, Atg4d during cell death is localizedto the mitochondrial membrane while ATG5 nuclear localization triggers
mitotic catastrophe [17,18]. Similarly, 10 μM salinomycin treatment of
MCF7 cells for 16 h downregulates Beclin1 and ATG12, which are in-
volved in the initiation andelongationof autophagy,while showing an in-
crease at initial timepoints (2–8h) and lower doses [19]. This observation
further supports the dual nature of autophagic response to salinomycin
treatment. Taken together, our observations suggest that the inhibition
of autophagic ﬂux by salinomycin is a secondary phenomenon.
4. Materials and Methods
4.1. Cells and Cell culture
PC3 (human prostate cancer cell line), SKBR3 (human breast cancer
cell lines) and murine embryonic ﬁbroblast (MEF) cells were cultured
in complete media (RPMI or DMEM media supplemented with 10%
FBS and 1% penicillin-streptomycin antibiotics) and maintained at
subconﬂuent conditions as mentioned in our previous publication [6].
4.2. Materials and reagents
Salinomycin, rapamycin, Chloroquine and saponin, were obtained
from Sigma-Aldrich and dissolved in their respective buffers as per
required concentrations. Rabbit-anti-LC3b, murine anti-actin was also
from Sigma-Aldrich whereas rabbit-anti-p62/SQSTRM1 was obtained
from Cellular Signalling Inc. Secondary antibodies such as anti-rabbit
HRP-conjugate and anti-murine HRP-conjugates were obtained from
Sigma-Aldrich. Adenovirus expressing GFP-LC3 and mTandem GFP-
RFP-LC3 were a kind gift from Dr. Junichi Sadoshima (Cell Biology
and Molecular Medicine Rutgers University, New Jersey Medical
School, USA).
4.3. Western blot
Cells cultured and treated as per experimental needs were lysed
using 100 μl of lysis buffer (RIPA buffer with protease inhibitors (Com-
plete Roche)) and mechanically sheared using 27 G ¾ inch needle and
syringe. The lysate was then centrifuged at 10,000 RPM to pellet the
cell debris and supernatant was collected. Protein concentration was
determined using Bradford assay and equal amounts of protein samples
were loaded onto the 15% PAGE gel and further proceeded as described
previously [6]. Themembranewas developed usingAmershamECL plus
Western blot developing kit (GE technologies).
4.4. Live cell imaging and confocal microscopy
Cells plated were infected with adenovirus expressing GFP-LC3 at a
viral titer of 50 MOI for 24 h and treated with lysotracker (100 nM)
for 30 min were treated with various concentrations of salinomycin
(0.1 μM to 1 μM) as mentioned accordingly and images were acquired
using Leica DMI6000 Florescence microscope equipped with a DFC365
monochrome camera and 63× oil objective (NA 0.6–1.4) for 1 h at a
rate of 10 s interval per frame and 8 z-stack slices of the cell is taken
after setting the lower and upper limit of the Z section deﬁning the
cell size. The images were further analyzed using ImageJ and Bitplane
Imaris software. For confocal imaging, cells pre-incubated with adeno-
virus expressing GFP-LC3 or mTandem GFP-RFP-LC3 at 50 MOI and
treated as mentioned above were washed with PBS and ﬁxed using 4%
paraformaldehyde for 20 min at 4 °C and mounted onto a slide with
mounting medium containing DAPI. Images were taken using laser
scanning confocal microscope (Zeiss).
4.5. Autophagic ﬂux analysis using ﬂow cytometry
A total of 100,000 cells/well, plated in 6-well plates were cultured
for 24 h and infected with GFP-LC3 or mTandem-GFP-RFP-LC3 for 24
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to monitor autophagy and autophagic ﬂux, for 6 h. The cells were
then washed with PBS, trypsinized and collected into an eppendorf
tube. Then, the cells were centrifuged and single cell suspensions were
made with 500 μl of PBS before being analyzed using Gallios Flow
Cytometer (GFP with FL1 and RFP with FL4 ﬁlters both excited using
488 laser). FlowJo software was used for analysis and representation
of histograms. The GFP-LC3 expressing cells are optionally incubated
with 0.05% of saponin for 10 min for the respective studies.
4.6. Statistics
All statistics (one-way ANOVA) were conducted using Prism (ver-
sion 6.0b) and SPSS (IBM version 20) software. A p-value of less than
0.05 was considered statistically signiﬁcant unless mentioned other-
wise. All the experiments were conducted as a minimum of three inde-
pendent replicates unless otherwise mentioned.
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